Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz

Moderna's stock experienced a significant surge, with gains reaching triple digits, following the release of favorable news about its cancer vaccine. Both Moderna and Merck saw a boost in their stock prices due to the positive buzz surrounding the potential cancer vaccine. Will mRNA technology make a comeback into the spotlight? The future looks promising for these companies as they continue to develop innovative healthcare solutions.